Given that VEGFA, IL2, and MPO all play roles in autoimmune diseases, in this study, kaempferol has been shown to bind well with these molecules, which suggests a potential avenue for therapeutic interventions targeted at these molecular interactions in the context of vitiligo. The gene discussed is MPO; the disease is autoimmune disease.